Skip to content
MedsAcross

Medicine

Valganciclovir 450 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Valganciclovir 450 mg tablet is a generic prescription medicine for oral use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C…

Key facts

Active ingredient (INN)
Valganciclovir
Brand
Sold under the generic name
Strength
450 mg
Dosage form
Tablet
Route
Oral
Packs
30 tablets, 60 tablets, 500 tablets and 20 more
Manufacturers
Aurobindo PharmaIndiaDr. Reddy's LaboratoriesIndiaCamber PharmaceuticalsIndiaStrides PharmaIndiaAjanta PharmaIndiaAmerican Health PackagingMajor PharmaceuticalsAvKAREAvPAKNorthStar Rx
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J05AB14 Valganciclovir
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
15 December 2014
Identifiers
RxCUI 313566DailyMed set ID d13cc8ad-eaf0-4ae6-89da-a850a08b1067, 85177859-e0f5-6d83-17f3-29cae1db96c3, 89a934f0-85a3-44c1-82e5-d09d1738e08d +9NDC 27241-158, 50268-787, 64380-161 +9Application ANDA212234, ANDA205166, ANDA200790 +3

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
30 tablet in 1 bottle43598-356-30Dr. Reddy's LaboratoriesIndia12 December 2017
60 tablet in 1 bottle43598-356-60Dr. Reddy's LaboratoriesIndia12 December 2017
500 tablet, film coated in 1 bottle55111-762-05Dr. Reddy's LaboratoriesIndia15 December 2014
60 tablet, film coated in 1 bottle55111-762-60Dr. Reddy's LaboratoriesIndia15 December 2014
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack55111-762-78Dr. Reddy's LaboratoriesIndia15 December 2014
60 tablet, film coated in 1 bottle, plastic64380-153-01Strides PharmaIndia12 September 2022
60 tablet, film coated in 1 bottle, plastic64380-161-01Strides PharmaIndia16 June 2025
60 tablet in 1 bottle27241-158-60Ajanta PharmaIndia26 December 2019
100 tablet in 1 bottle65862-753-01Aurobindo PharmaIndia31 March 2016
500 tablet in 1 bottle65862-753-05Aurobindo PharmaIndia31 March 2016
180 tablet in 1 bottle65862-753-18Aurobindo PharmaIndia31 March 2016
60 tablet in 1 bottle65862-753-60Aurobindo PharmaIndia31 March 2016
1000 tablet in 1 bottle65862-753-99Aurobindo PharmaIndia31 March 2016
10 tablet, film coated in 1 blister pack31722-832-31Camber PharmaceuticalsIndia18 March 2016
10 tablet, film coated in 1 carton31722-832-32Camber PharmaceuticalsIndia18 March 2016
60 tablet, film coated in 1 bottle31722-832-60Camber PharmaceuticalsIndia18 March 2016
20 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack68084-965-19American Health Packaging6 November 2024
30 blister pack in 1 box, unit-dose / 1 tablet, film coated in 1 blister pack68084-965-25American Health Packaging16 January 2015
60 tablet, film coated in 1 bottle42291-973-60AvKARE21 December 2023
20 blister pack in 1 box, unit-dose / 1 tablet, film coated in 1 blister pack50268-787-12AvPAK27 July 2016
30 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack0904-6796-04Major Pharmaceuticals18 March 2016
20 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack0904-6796-10Major Pharmaceuticals18 March 2016
60 tablet in 1 bottle72603-750-01NorthStar Rx1 March 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 29 March 2001Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Valganciclovir 450 mg tablet.

Compare 1

Other strengths and forms of Valganciclovir

Clinical summary

Valganciclovir is a cytomegalovirus nucleoside analog DNA polymerase inhibitor indicated for adult Patients, among other approved uses. It is available as powder for oral solution and tablets. MedsAcross supplies Valganciclovir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Valganciclovir

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Valganciclovir 450 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.